Steris | STE - Current Assets



Steris reported $2.06B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
3M USD 13.43B 2.23B Jun/2025
Avanos Medical USD 356M 3.6M Jun/2025
Baxter International USD 7.04B 1.82B Mar/2025
Becton, Dickinson and Co. USD 9B 331M Jun/2025
Boston Scientific USD 7.34B 415M Mar/2025
CONMED USD 657.78M 18.78M Jun/2025
Cooper Companies USD 2.14B 12.1M Jul/2025
Dexcom USD 5.03B 476.4M Jun/2025
Ecolab USD 7.08B 994.7M Jun/2025
Edwards Lifesciences USD 6.21B 72.7M Mar/2025
Fortive USD 3.68B 979.3M Jun/2025
Getinge SEK 18.16B 1.83B Dec/2024
Globus Medical USD 1.73B 19.79M Jun/2025
Haemonetics USD 913.16M 21.82M Jun/2025
Hologic USD 3.42B 212.7M Jun/2025
Idexx Laboratories USD 1.36B 44.74M Jun/2025
Insulet USD 2.28B 48.7M Jun/2025
Integra LifeSciences USD 1.14B 35.58M Jun/2025
Intuitive Surgical USD 12.47B 592.4M Jun/2025
J&J USD 71.55B 15.66B Mar/2025
Masimo USD 1.27B 85.8M Jun/2025
Olympus JPY 684.04B 4.6B Jun/2025
Owens Minor USD 2.21B 185.18M Mar/2025
ResMed USD 3.51B 297.18M Jun/2025
Steris USD 2.06B 57.04M Jun/2025
Stryker USD 13B 19M Jun/2025
Tandem Diabetes Care USD 614.82M 48.62M Jun/2025
Teleflex USD 1.72B 184.95M Jun/2025
Thermo Fisher Scientific USD 24.58B 1.21B Jun/2025
Zimmer Biomet Holdings USD 5.05B 536.3M Jun/2025